Tetsuya So Selected Research

Tetsuya So Research Topics

Disease

19	Neoplasms (Cancer) 04/2021 - 04/2004
13	Lung Neoplasms (Lung Cancer) 04/2021 - 04/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2005
3	Neoplasm Metastasis (Metastasis) 01/2009 - 01/2005
2	Adenocarcinoma of Lung 11/2020 - 05/2006
2	Fistula 03/2017 - 09/2011
2	Adenocarcinoma 01/2011 - 08/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010 - 05/2006
2	Carcinoma (Carcinomatosis) 01/2009 - 01/2005
2	Large Cell Carcinoma 03/2007 - 09/2006
2	Disease Progression 12/2005 - 01/2005
1	Pleural Effusion (Pleural Effusions) 03/2017
1	Pleural Empyema (Pyothorax) 03/2017
1	Empyema 03/2017
1	Granuloma 09/2014
1	Neoplasm Micrometastasis 12/2010
1	Testicular Neoplasms (Testicular Cancer) 04/2010
1	Pleurisy (Pleuritis) 01/2009
1	Brain Neoplasms (Brain Tumor) 01/2009
1	Meningeal Carcinomatosis 01/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2007
1	Melanoma (Melanoma, Malignant) 07/2005
1	Carcinogenesis 07/2005
1	Breast Neoplasms (Breast Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 11/2020 - 01/2005
4	Peptides (Polypeptides)IBA 11/2020 - 04/2004
4	Neoplasm Antigens (Tumor Antigens)IBA 09/2006 - 07/2005
3	Proteins (Proteins, Gene)FDA Link 12/2010 - 04/2004
3	Immunoglobulin G (IgG)IBA 09/2006 - 12/2005
2	HLA-A24 AntigenIBA 03/2007 - 05/2005
2	Amino Acids FDA Link 05/2006 - 04/2004
2	PhytohemagglutininsIBA 05/2006 - 07/2005
1	AldehydesIBA 01/2022
1	A 17 (A-17)IBA 04/2021
1	HLA-B15 AntigenIBA 11/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014
1	R-CHOP protocolIBA 12/2014
1	Rituximab (Mabthera)FDA Link 12/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2014
1	Prednisolone (Predate)FDA LinkGeneric 12/2014
1	Vincristine (Oncovin)FDA LinkGeneric 12/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2012
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 09/2011
1	beta CateninIBA 12/2010
1	ParaffinIBA 12/2010
1	Cadherins (E-Cadherin)IBA 12/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010
1	Vascular Endothelial Growth Factor CIBA 12/2010
1	alpha Catenin (alpha E-Catenin)IBA 12/2010
1	gamma Catenin (Plakoglobin)IBA 12/2010
1	ErbB Receptors (EGF Receptor)IBA 08/2010
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 08/2010
1	Cisplatin (Platino)FDA LinkGeneric 01/2009
1	PicibanilIBA 01/2009
1	Gefitinib (Iressa)FDA Link 01/2009
1	Messenger RNA (mRNA)IBA 09/2007
1	Complement System Proteins (Complement)IBA 09/2007
1	HLA-A Antigens (HLA-A)IBA 03/2007
1	Complementary DNA (cDNA)IBA 09/2006
1	HLA-B Antigens (HLA-B)IBA 05/2006
1	HLA-A*26 antigenIBA 07/2005
1	Histocompatibility Antigens Class IIBA 07/2005
1	Cytochrome P-450 CYP3AIBA 05/2005
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2005
1	Tamoxifen FDA LinkGeneric 05/2005
1	VaccinesIBA 05/2005
1	CarbohydratesIBA 03/2005
1	Carcinoembryonic AntigenIBA 03/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2005
1	Biological ProductsIBA 03/2005
1	CA-125 Antigen (CA 125 Antigen)IBA 03/2005
1	squamous cell carcinoma-related antigenIBA 03/2005
1	Tumor Biomarkers (Tumor Markers)IBA 03/2005

Therapy/Procedure

4	Immunotherapy 04/2010 - 05/2005
1	Heterologous Transplantation (Xenotransplantation) 11/2020
1	Chest Tubes (Chest Tube) 03/2017
1	Thoracoplasty 03/2017
1	Curettage 03/2017
1	Argon Plasma Coagulation 09/2014
1	Tracheostomy 09/2014
1	Conservative Treatment 09/2011
1	Segmental Mastectomy (Lumpectomy) 01/2011
1	Drug Therapy (Chemotherapy) 01/2009
1	Radiotherapy 01/2009
1	Ventriculoperitoneal Shunt 01/2009